VTGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - VistaGen Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.2328 USD 1.13%

Market Cap: $9.6m

V	VistaGen Therapeutics Inc NASDAQ:VTGN	US

Profitability Summary

VistaGen Therapeutics Inc's profitability score is 7/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-5.684%

Negative 3Y Average Operating Margin

-3.675%

Declining Operating Margin

13.286% > -5.684%

Negative Net Margin

-5.491%

Negative 3Y Average Net Margin

-3.336%

Declining Net Margin

13.249% > -5.491%

Negative Free Cash Flow Margin

-5.247%

Negative 3Y Average Free Cash Flow Margin

-3.355%

Declining Free Cash Flow Margin

11.906% > -5.247%

Negative ROE

-132%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1.610%

Declining ROIC

-1.860% > -2.986%

View All

Hide

Collapse

7 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.